Европейски съюз -
норвежки -
EMA (European Medicines Agency)
xarelto
bayer ag - rivaroksaban - arthroplasty, replacement; venous thromboembolism - antithrombotic agents - xarelto, co-gis med acetylsalisylsyre (asa) alene eller sammen med asa pluss clopidogrel eller tiklopidin, er indikert for forebygging av atherothrombotic hendelser hos voksne pasienter etter et akutt koronar syndrom (acs) med forhøyet ved biomarkører. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. forebygging av venøs tromboembolisme (vte) hos voksne pasienter som gjennomgår valgfri hofte- eller kneutskifting. behandling av dyp venetrombose (dvt) og lungeemboli (pe), og forebygging av tilbakevendende dvt og pe i voksne. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
Норвегия -
норвежки -
Statens legemiddelverk
adalat 10 mg
bayer ab - solna - nifedipin - tablett, filmdrasjert - 10 mg
Норвегия -
норвежки -
Statens legemiddelverk
ciproxin 250 mg
bayer ab - solna - ciprofloksacinhydroklorid - tablett, filmdrasjert - 250 mg
Норвегия -
норвежки -
Statens legemiddelverk
glucobay 50 mg
bayer ab - solna - akarbose - tablett - 50 mg
Норвегия -
норвежки -
Statens legemiddelverk
nimotop 30 mg
bayer ab - solna - nimodipin - tablett, filmdrasjert - 30 mg
Норвегия -
норвежки -
Statens legemiddelverk
glucobay 100 mg
bayer ab - solna - akarbose - tablett - 100 mg
Европейски съюз -
норвежки -
EMA (European Medicines Agency)
nubeqa
bayer ag - darolutamide - prostatic neoplasmer, kastrering-resistant - endokrin terapi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.
Норвегия -
норвежки -
myHealthbox
attribut twin
bayer ag - en salgsenhet inneholder 2 x 300 g attributt sg 70 og 500 ml hussar od.